Mills L H, Lee A J, Parlow A F, Zhu B T
Department of Basic Pharmaceutical Sciences, College of Pharmacy, University of South Carolina, 700 Sumter Street, Columbia, SC 29208, USA.
Cancer Res. 2001 Aug 1;61(15):5764-70.
We hypothesize that the endogenously present lipoidal estrogen fatty acid esters may have a stronger mitogenic action in the fat-rich mammary tissues than in the uterus. To test this hypothesis, we compared the activity of estradiol-17beta-stearate (E(2)-17beta-S) with that of estradiol-17beta (E(2)) in stimulating the growth of mammary glandular cells versus the growth of uterine endometrial cells in ovariectomized female Sprague Dawley rats. Experimentally, an estimated 0.5 or 5 nmol of E(2)-17beta-S or E(2) was released daily to ovariectomized female rats through an Alzet pump implanted under the back skin of the animal for 10 or 23 days. The growth-stimulatory effect of E(2)-17beta-S and E(2) on mammary glandular cells was determined according to 5-bromo-2'-deoxyuridine labeling indices, and their effect on the uterus was determined by measuring both the 5-bromo-2'-deoxyuridine labeling index and the uterine wet weight. Our results showed that chronic treatment of ovariectomized female rats with 0.5 or 5 nmol/day E(2)-17beta-S for 10 or 23 days had a stronger stimulatory effect on mammary glandular cell proliferation than treatment with equimolar doses of E(2). In the uterus, however, E(2) was more active in stimulating the proliferation of uterine endometrial cells than E(2)-17beta-S at equimolar doses. Our results demonstrated, for the first time, that a naturally occurring estradiol-17beta-fatty acid ester has a differential, strong mitogenic effect in the fat-rich mammary tissues, and this effect was not observed with E(2). It is tempting to suggest that the fatty acid esters of the endogenous estrogens and their bioactive metabolites (e.g., 4-hydroxyestradiol and 16alpha-hydroxyestrone) may be of unique importance for stimulating cell growth and possibly also for inducing tumor formation in the fat-rich mammary tissues as compared with the uterus. More studies are warranted to test these ideas.
我们推测,内源性存在的脂类雌激素脂肪酸酯在富含脂肪的乳腺组织中可能比在子宫中具有更强的促有丝分裂作用。为了验证这一推测,我们比较了雌二醇-17β-硬脂酸酯(E(2)-17β-S)与雌二醇-17β(E(2))在去卵巢的雌性Sprague Dawley大鼠中刺激乳腺细胞生长与子宫子宫内膜细胞生长的活性。实验中,通过植入动物背部皮肤下的Alzet泵,每天向去卵巢的雌性大鼠释放约0.5或5 nmol的E(2)-17β-S或E(2),持续10或23天。根据5-溴-2'-脱氧尿苷标记指数确定E(2)-17β-S和E(2)对乳腺细胞的生长刺激作用,并通过测量5-溴-2'-脱氧尿苷标记指数和子宫湿重来确定它们对子宫的作用。我们的结果表明,用0.5或5 nmol/天的E(2)-17β-S对去卵巢的雌性大鼠进行10或23天的慢性治疗,对乳腺细胞增殖的刺激作用比用等摩尔剂量的E(2)治疗更强。然而,在子宫中,等摩尔剂量的E(2)在刺激子宫内膜细胞增殖方面比E(2)-17β-S更具活性。我们的结果首次证明,天然存在的雌二醇-17β-脂肪酸酯在富含脂肪的乳腺组织中具有不同的、强烈的促有丝分裂作用,而E(2)则没有这种作用。可以推测,与子宫相比,内源性雌激素的脂肪酸酯及其生物活性代谢物(如4-羟基雌二醇和16α-羟基雌酮)对于刺激富含脂肪的乳腺组织中的细胞生长以及可能诱导肿瘤形成可能具有独特的重要性。需要更多的研究来验证这些观点。